<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05086861</url>
  </required_header>
  <id_info>
    <org_study_id>15/P/094</org_study_id>
    <nct_id>NCT05086861</nct_id>
  </id_info>
  <brief_title>Oesophageal Pacing to Check Left Atrial Posterior Wall Isolation</brief_title>
  <official_title>Oesophageal Pacing to Check Left Atrial Posterior Wall Isolation: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Plymouth NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Plymouth NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing hybrid AF ablation second stage catheter ablation have the posterior left&#xD;
      atrium mapped to see it if is electrically isolated. This is done via a standard&#xD;
      electrophysiogical study in accordance with routine clinical practice.&#xD;
&#xD;
      Investigators propose to check left atrium posterior wall isolation via oesophageal pacing&#xD;
      and compare this to findings from invasive study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oesophageal temporary pacing of the heart is an established treatment in heart block and&#xD;
      several catheters are licenced for this purpose with minimal procedural risks. Due to the&#xD;
      position of the oesophagus, pacing from the oesophagus could sense and pace the posterior&#xD;
      left atrium. If the posterior wall could be demonstrated to be electrically isolated with&#xD;
      oesophageal pacing then invasive electrophysiological study such as the second stage of a&#xD;
      hybrid AF ablation would be unnecessary.&#xD;
&#xD;
      This would save patients from undergoing invasive left atrial mapping and exposure to the&#xD;
      consequent risks of the procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 23, 2016</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left atrial posterior wall isolation</measure>
    <time_frame>Through study completion, an average of 4 years</time_frame>
    <description>Measured via invasive left atrial mapping</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>Through study completion, an average of 4 years</time_frame>
    <description>Documentation of the number of complications caused by the oesophageal pacing procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility of using device</measure>
    <time_frame>Through study completion, an average of 4 years</time_frame>
    <description>The success rate of left atrial posterior wall isolation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Persistent Atrial Fibrillation</condition>
  <condition>Atrial Fibrillation Ablation</condition>
  <arm_group>
    <arm_group_label>Oesophageal Pacing Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing atrial fibrillation ablation to isolate the left atrial posterior wall via catheter or staged hybrid ablation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oesophageal pacing after left atrial posterior wall isolation</intervention_name>
    <description>Following AF ablation with the aim of isolating the left atrial posterior wall oesophageal pacing and sensing is performed to check for left atrial posterior wall. entrance and exit block.</description>
    <arm_group_label>Oesophageal Pacing Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: â€¢ subjects capable of giving informed consent,&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  Aged between 18 and 80 years&#xD;
&#xD;
          -  Undergoing ablation under general anaesthetic with planned isolation of the left&#xD;
             atrial posterior wall or who have previously undergone either catheter or surgical&#xD;
             ablation for AF with LA posterior wall isolation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable or willing to give fully informed written consent&#xD;
&#xD;
          -  Turned down for general anaesthetic&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Terminal illness&#xD;
&#xD;
          -  Any other significant disease or disorder which, in the opinion of the investigator,&#xD;
             may either put the participant at risk because of participation in the study, or may&#xD;
             influence the result of the study, or the participant's ability to participate.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy Haywood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Plymouth NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Derriford Hospital</name>
      <address>
        <city>Plymouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>August 29, 2019</study_first_submitted>
  <study_first_submitted_qc>October 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Oesophageal Pacing</keyword>
  <keyword>Hybrid Ablation</keyword>
  <keyword>Persistent Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

